Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Essa Pharma (EPIX)

Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,022
  • Shares Outstanding, K 44,389
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,580 K
  • EBIT $ -34 M
  • EBITDA $ -34 M
  • 60-Month Beta 1.63
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.57

Options Overview Details

View History
  • Implied Volatility 339.87% ( +78.61%)
  • Historical Volatility 29.07%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 339.87% on 12/20/24
  • IV Low 26.26% on 06/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 3,872
  • Open Int (30-Day) 3,783

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 2
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5700 +1.91%
on 12/19/24
1.8700 -14.44%
on 11/25/24
-0.1300 (-7.51%)
since 11/20/24
3-Month
1.4000 +14.29%
on 11/01/24
6.7663 -76.35%
on 09/30/24
-4.8600 (-75.23%)
since 09/20/24
52-Week
1.4000 +14.29%
on 11/01/24
11.6700 -86.29%
on 02/07/24
-4.5000 (-73.77%)
since 12/20/23

Most Recent Stories

More News
ESSA Pharma: Fiscal Q4 Earnings Snapshot

ESSA Pharma: Fiscal Q4 Earnings Snapshot

EPIX : 1.6000 (unch)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company that, prior to the discontinuation of its clinical...

EPIX : 1.6000 (unch)
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

Efficacy signals observed will not achieve ESSA's target product profile in patients with metastatic castration-resistant prostate cancer naïve to...

EPIX : 1.6000 (unch)
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with mCRPC Phase 2 dose expansion...

EPIX : 1.6000 (unch)
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for treatment...

EPIX : 1.6000 (unch)
ESSA Pharma: Fiscal Q3 Earnings Snapshot

ESSA Pharma: Fiscal Q3 Earnings Snapshot

EPIX : 1.6000 (unch)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024

On track to report updated Phase 1 masofaniten plus enzalutamide dose escalation data in patients with mCRPC naïve to second generation antiandrogens in the...

EPIX : 1.6000 (unch)
ESSA Pharma to Present at the JonesHealthcare Seaside Summit

/CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 1.6000 (unch)
ESSA Pharma to Present at the Jefferies Global Healthcare Conference

/CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the...

EPIX : 1.6000 (unch)
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in Phase 1 dose escalation in patients with...

EPIX : 1.6000 (unch)

Business Summary

ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.

See More

Key Turning Points

3rd Resistance Point 1.6933
2nd Resistance Point 1.6667
1st Resistance Point 1.6333
Last Price 1.6000
1st Support Level 1.5733
2nd Support Level 1.5467
3rd Support Level 1.5133

See More

52-Week High 11.6700
Fibonacci 61.8% 7.7469
Fibonacci 50% 6.5350
Fibonacci 38.2% 5.3231
Last Price 1.6000
52-Week Low 1.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar